The second report of a new hypomyelinating disease due to a defect in the VPS11 gene discloses a massive lysosomal involvement by Hörtnagel, Konstanze, Krägeloh-Mann, Inge, Bornemann, Antje, Döcker, Miriam, Biskup, Saskia, Mayrhofer, Heidi, Battke, Florian, du Bois, Gabriele, Harzer, Klaus

Get full text

Aberrant splicing is a common mutational mechanism in MKS1, a key player in Meckel-Gruber syndrome by Frank, Valeska, Ortiz Brüchle, Nadina, Mager, Silke, Frints, Susanna G. M., Bohring, Axel, du Bois, Gabriele, Debatin, Irmgard, Seidel, Heide, Senderek, Jan, Besbas, Nesrin, Todt, Unda, Kubisch, Christian, Grimm, Tiemo, Teksen, Fulya, Balci, Sevim, Zerres, Klaus, Bergmann, Carsten

Get full text

Clinical report of 8 patients with 49,XXXXY syndrome: Delineation of the facial gestalt and depiction of the clinical spectrum by Burgemeister, Anna L., Daumiller, Eva, du Bois, Gabriele, Graul-Neumann, Luitgard M., Köhler, Birgit, Knecht, Susanne, Burgemeister, Stefan, Gronwald, Sarah, Maurer, Martin H., Zirn, Birgit

Get full text

Aberrant splicing is a common mutational mechanism inMKS1, a key player in Meckel-Gruber syndrome by Frank, Valeska, Ortiz Brüchle, Nadina, Mager, Silke, Frints, Susanna G. M., Bohring, Axel, du Bois, Gabriele, Debatin, Irmgard, Seidel, Heide, Senderek, Jan, Besbas, Nesrin, Todt, Unda, Kubisch, Christian, Grimm, Tiemo, Teksen, Fulya, Balci, Sevim, Zerres, Klaus, Bergmann, Carsten

Get full text

Interstitial deletion del(10)(q25.2q25.3 ∼ 26.11)-case report and review of the literature by Kehrer-Sawatzki, Hildegard, Daumiller, Eva, Müller-Navia, Jutta, Kendziorra, Heidemarie, Rossier, Eva, du Bois, Gabriele, Barbi, Gotthold

Get full text

Interstitial deletion del(10)(q25.2q25.3 ∼ 26.11) : case report and review of the literature by KEHRER-SAWATZKI, Hildegard, DAUMILLER, Eva, MÜLLER-NAVIA, Jutta, KENDZIORRA, Heidemarie, ROSSIER, Eva, DU BOIS, Gabriele, BARBI, Gotthold

Get full text

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial by Chekerov, Radoslav, Hilpert, Felix, Mahner, Sven, El-Balat, Ahmed, Harter, Philipp, De Gregorio, Nikolaus, Fridrich, Claudius, Markmann, Susanne, Potenberg, Jochem, Lorenz, Ralf, Oskay-Oezcelik, Guelten, Schmidt, Marcus, Krabisch, Petra, Lueck, Hans-Joachim, Richter, Rolf, Braicu, Elena Ioana, du Bois, Andreas, Sehouli, Jalid, Lichtenegger, Werner, Yalcinkaya, Isil, Kittner, Marion, Konwert, Ellen, Keller, Maren, Mustea, Alexander, Koensgen-Mustea, Dominique, Pietzner, Klaus, Camara, Oumar, Wimberger, Pauline, Elser, Gabriele, Polleis, Sandra

Get full text

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial by Shannon, Catherine M, Joly, Florence, Sehouli, Jalid, Canzler, Ulrich, Schmalfeldt, Barbara, Dean, Andrew P, Hein, Alexander, Zeimet, Alain G, Petit, Thierry, Marmé, Frederik, El-Balat, Ahmed, Glasspool, Rosalind, Mahner, Sven, Park-Simon, Tjoung-Won, Mouret-Reynier, Marie-Ange, Costan, Cristina, Reinthaller, Alexander, Goh, Jeffrey C, Kommoss, Stefan, Kurtz, Jean-Emmanuel, Ackermann, Sven, Anthuber, Christoph, Aydogdu, Mustafa, Baldauf, Angelika, Behringer, Dirk, Belau, Antje, Bender, Alexandra, Burges, Alexander, Canzler, Ulrich, Daabach, Trygve, Deryal, Mustafa, El-Balat, Ahmed, Fehm, Tanja, Feisel-Schwickardi, Gabriele, Frank, Matthias, Gebauer, Gerhard, Gerber, Bernd, Gerhardt, Axel, Grafe, Andrea, Griesshammer, Martin, Gropp-Meier, Martina, Hager, Dietrich, Hannig, Carla Verena, Hantschmann, Peer, Harter, Philipp, Hauzenberger, Tanja, Herwig, Uwe, Hilpert, Felix, Jackisch, Christian, Krieger, Peter, Lampe, Björn, Lex, Benno, Lorenz, Ralf, Mahner, Sven, Mallmann, Peter, Marmé, Frederik, Möbus, Volker, Müller, Thomas, Neunhöffer, Tanja, Ober, Angelika, Rautenberg, Beate, Reiter, Wilhelm, Schmalfeldt, Barbara, Scholz, Heinz, Simon, Eike, Sperfeld, Antje, Terhaag, Jürgen, Uleer, Christoph, Vogel, Susanne, Voß, Hermann, Winkler, Ulrich, Wischnik, Arthur, Zorr, Andreas, Glasspool, Ros, Jones, Rachel, Lafleur, Judith, Marth, Christian, Baron-Hay, Sally, Beale, Philip, Begbie, Stephen, Harvey, Sandra, Matos, Marco, Meniawy, Tarek, Olesen, Inger, Shannon, Catherine, Abadie-Lacourtoisie, Sophie, Arsene, Olivier, Barthier, Sophie, Catala, Stéphanie, Dohollou, Nadine, Garnier-Tixidré, Claire, Guardiola, Emmanuel, Hardy-Bessard, Anne-Claire, Joly, Florence, Levache, Charles-Briac, Longo, Raffaele, Lortholary, Alain, Meunier, Jérôme, Raban, Nadia, Vannetzel, Jean-Michel

Get full text

Addition of vandetanib to pegylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A randomized phase I/II study of the AGO Study Group (AGO-OVAR 2.13) by Harter, Philipp, Sehouli, Jalid, Kimmig, Rainer, Rau, Jörn, Hilpert, Felix, Kurzeder, Christian, Elser, Gabriele, du Bois, Andreas

Get full text

Influence of Intravenous Contrast Agent on Dose Calculation in 3-D Treatment Planning for Radiosurgery of Cerebral Arteriovenous Malformations by Zabel-du Bois, Angelika, Ackermann, Benjamin, Hauswald, Henrik, Schramm, Oliver, Sroka-Perez, Gabriele, Huber, Peter, Debus, Jürgen, Milker-Zabel, Stefanie

Get full text

Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study by Pulford, David J, Harter, Philipp, Floquet, Anne, Barrett, Catherine, Suh, Dong Hoon, Friedlander, Michael, Arranz, José Angel, Hasegawa, Kosei, Tada, Hiroomi, Vuylsteke, Peter, Mirza, Mansoor R, Donadello, Nicoletta, Scambia, Giovanni, Johnson, Toby, Cox, Charles, Chan, John K, Imhof, Martin, Herzog, Thomas J, Calvert, Paula, Wimberger, Pauline, Berton-Rigaud, Dominique, Lim, Myong Cheol, Elser, Gabriele, Xu, Chun-Fang, du Bois, Andreas

Get full text